US Patent 11753474 Anti-Dectin-2 antibodies
Patent 11753474 was granted and assigned to Bolt Biotherapeutics on September, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 13 Sep, 2023
Golden AI
Edits made to:
Infobox (+14 properties)
Article (+436 characters)
US Patent 11753474 Anti-Dectin-2 antibodies
Article
The invention relates to dendritic cell-associated C-type lectin 2 (Dectin-2) binding agents, nucleic acids comprising the inventive binding agents, vectors and cells comprising the inventive nucleic acids, and compositions thereof. The invention also relates to methods of providing the inventive binding agents, methods for treating a disease, disorder, or condition in a mammal, and methods of stimulating an antigen presenting cell.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
11753474
Patent Inventor Names
David Dornan
Justin A. Kenkel
Karla A. Henning
Shelley Erin Ackerman
Date of Patent
September 12, 2023
Patent Application Number
17592323
Date Filed
February 3, 2022
Patent Primary Examiner
Find more entities like US Patent 11753474 Anti-Dectin-2 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
